Astellas partners with Insilico, Harvard; Zambon gets FDA's fast track status for lung drug
→ Another day, another Insilico deal. Weeks after unveiling a tie-up with Germany’s Boehringer Ingelheim — the prolific dealmaking powers-that-be at the Hong Kong-based AI …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
